Evolving contract manufacturers from approved suppliers to strategic partners fosters long-term product development growth. OEMs and CMOs share best practices to improve operational efficiencies and implement risk-mitigating strategies in supply chain management
R&D leaders share ways they leverage data-driven insights to inform design iteration and integrate AI-enhanced tools into workflows to create next-generation implants that deliver on promises of improved patient care.
Take a deep dive into ways advanced 3D printing techniques, design freedom and creative minds turn inventive ideas into innovative implants.
This session will showcase real-world applications that demonstrate the transformative potential of advanced robotics and automated quality control.
Orthopedics is entering a new era, driven by advanced materials that overcome the manufacturing and healing limitations of traditional alloys, polymers and biomaterials. This rapid-fire session allows OEMs to hear how three materials companies are developing innovative solutions for orthopedic implants and provides recommendations for next-gen devices.
OMTEC Award winners will share lessons learned and actionable advice from their experiences in pushing device design forward, leading with a commitment to excellence and coming up with breakthrough concepts.
Traditional Torque Limiting Devices require stringent recalibration every six months, creating logistical burdens for OEMs. Intech presents InfiniTLD, the first maintenance-free, reusable TLD that eliminates the need for recalibration.
Bacterial endotoxin contamination on orthopedic devices can result in adverse regulatory and patient impact, and considerable product cost. This presentation discusses the types of devices that need to be tested for product release, sources of endotoxin and primary endotoxin test methods.
ADDITIVE PLUS is a framework beyond traditional 3D printing. This session explores Lincotek's integrated suite of services, from Design for AM and advanced high-performance coatings to streamlined post-processing and packaging, delivers significant cost reductions and efficiency improvements.
FDA has new approaches to navigating the complex regulatory landscape and systems in place to remove the burdens of securing marketing clearance for innovative devices that promise to improve patient care.
